Find insight on Jamieson Wellness, Sanofi, Regeneron Pharmaceuticals and more in the latest Market Talks covering health care.

Jamieson Wellness Inc. reported past first-quarter 2026 results with sales of C$169.75 million and net income of C$8.81 million, reversing a loss a year earlier, and affirmed a quarterly dividend of C$0.23 per share payable on June 15, 2026. The sharp swing from a loss per share of C$0.06 to earnings of C$0.21 highlights a meaningful improvement in profitability from continuing operations. We’ll now examine how Jamieson Wellness’s return to profitability and continued dividend payments shape...

Jamieson Wellness: recent performance snapshot Jamieson Wellness (TSX:JWEL) has drawn investor attention after a stretch of mixed near term returns, with the stock down roughly 2.5% over the past day and 3.7% over the past week. See our latest analysis for Jamieson Wellness. Despite the recent 1-day and 7-day share price declines, Jamieson Wellness is still sitting at CA$36.76, with its 90-day share price return of 8.40% and 1-year total shareholder return of 29.34% suggesting earlier...

Jamieson Wellness (TSE:JWEL) management said fiscal 2025 delivered another year of strong execution across core markets, led by outsized gains in China and continued growth in its branded portfolio. On the company’s fourth-quarter earnings call, President and CEO Mike Pilato and CFO Chris Snowden hi

Jamieson Wellness Inc (JWLLF) reports a robust 13.4% revenue increase, driven by significant growth in China and strategic brand investments.

Jamieson Wellness (JWEL.TO) after trade Thursday said its fourth-quarter profit and revenue rose yea

Jamieson Wellness (JWEL.TO), trading at 52 week highs, on Thursday said it received approval from th

Most readers would already be aware that Jamieson Wellness' (TSE:JWEL) stock increased significantly by 7.2% over the...